4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonists.

Bioorg Med Chem Lett

Division of Psychiatry, Research and Early Development Europe, Johnson and Johnson Pharmaceutical Research and Development, Jarama 75, 47007 Toledo, Spain.

Published: January 2006

A novel series of 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives has been prepared and their synthesis described herein. In vitro affinities for delta-, mu-, and kappa-opioid receptors, as well as the functional activity in the [(35)S]GTPgammaS assay are reported. The most potent and selective delta-opioid agonist 18a exhibited a K(i) of 18 nM, and was >258-fold and 28-fold selective over mu- and kappa-receptors, respectively; the compound is a full agonist with an EC(50) value of 14 nM.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.09.025DOI Listing

Publication Analysis

Top Keywords

4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives
8
selective delta-opioid
8
derivatives novel
4
novel class
4
class selective
4
delta-opioid agonists
4
agonists novel
4
novel series
4
series 4-phenyl-4-[1h-imidazol-2-yl]-piperidine
4
derivatives prepared
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!